Product category
Pediatrics
16 public development records. Search this category and review proposed presentations, evidence limits and attributed references.
- Records
- 16
- Medicines
- 16
- Devices / diagnostics
- 0
- Presentations represented
- 5
Public development records
Pediatrics records
Category placement supports navigation. It does not establish an approved indication, suitability for a particular patient group, prescription status or eligibility for supply.
Showing 16 of 16 records
Portfolio records
| Record | Dosage form / type | Proposed strength / configuration | Proposed pack | Status |
|---|---|---|---|---|
| Amoxicillin + clavulanic acid Powder for oral suspensionLP-014 | Powder for oral suspensionMedicine | 125 mg + 31.25 mg/5 mL; 250 mg + 62.5 mg/5 mL; 400 mg + 57 mg/5 mL | Bottle for reconstitution 60 mL / 100 mL | Development record |
| Amoxicillin Powder for oral suspensionLP-013 | Powder for oral suspensionMedicine | 125 mg/5 mL; 250 mg/5 mL; 400 mg/5 mL | Bottle for reconstitution 60 mL / 100 mL | Development record |
| Azithromycin Powder for oral suspensionLP-015 | Powder for oral suspensionMedicine | 200 mg/5 mL | Bottle for reconstitution 15 mL / 30 mL | Development record |
| Cefalexin Powder for oral suspensionLP-016 | Powder for oral suspensionMedicine | 125 mg/5 mL; 250 mg/5 mL | Bottle for reconstitution 60 mL | Development record |
| Cefixime Powder for oral suspensionLP-017 | Powder for oral suspensionMedicine | 100 mg/5 mL | Bottle for reconstitution 30 mL / 60 mL | Development record |
| Cetirizine SyrupLP-003 | SyrupMedicine | 5 mg/5 mL | Bottle 60 mL | Development record |
| Chlorpheniramine maleate SyrupLP-004 | SyrupMedicine | 2 mg/5 mL | Bottle 60 mL | Development record |
| Ibuprofen Oral suspensionLP-006 | Oral suspensionMedicine | 100 mg/5 mL | Bottle 60 mL / 100 mL | Development record |
| Metronidazole Oral suspensionLP-018 | Oral suspensionMedicine | 200 mg/5 mL | Bottle 60 mL / 100 mL | Development record |
| Multivitamin SyrupLP-007 | SyrupMedicine | Vitamins A, D, E, C, B1, B2, B3, B5, B6, B12; quantities to be confirmedUnresolved field: the exact value is not established. The record page shows the full catalogue wording. | Bottle 60 mL / 100 mL | Development record |
| Paracetamol SuppositoriesLP-008 | SuppositoryMedicine | 125 mg; 250 mg | Strip or blister; carton 10 units | Development record |
| Paracetamol SyrupLP-009 | SyrupMedicine | 120 mg/5 mL; 250 mg/5 mL | Bottle 60 mL / 100 mL | Development record |
| Salbutamol SyrupLP-010 | SyrupMedicine | 2 mg/5 mL | Bottle 60 mL / 100 mL | Development record |
| Sulfamethoxazole + Trimethoprim Oral suspensionLP-019 | Oral suspensionMedicine | 200 mg + 40 mg/5 mL | Bottle 60 mL / 100 mL | Development record |
| Zinc sulfate Dispersible tabletLP-011 | Dispersible tabletMedicine | 10 mg; 20 mg | Blister 10 x 10 dispersible tablets | Development record |
| Zinc sulfate SyrupLP-012 | SyrupMedicine | 10 mg per 5 mL | Bottle 60 mL / 100 mL | Development record |
No matching record.
Try a broader generic name, another presentation or a portfolio reference.
Professional enquiries
Enquire about this product category.
Include the generic name or portfolio reference, your organisation and destination country.